Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up
SCHOLARLY PUBLICATION

Executive Summary: Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America

Stanford T. Shulman, Alan L. Bisno, Herbert W. Clegg, Michael A. Gerber, Edward L. Kaplan, Grace Lee, Judith M. Martin, Chris Van Beneden

📖 Clinical Infectious Diseases → 📅 2012-09-09 🔗 DOI: 10.1093/cid/cis847
View Journal Profile → View Official Paper ↗

📄 Abstract

The guideline is intended for use by healthcare providers who care for adult and pediatric patients with group A streptococcal pharyngitis. The guideline updates the 2002 Infectious Diseases Society of America guideline and discusses diagnosis and management, and recommendations are provided regarding antibiotic choices and dosing. Penicillin or amoxicillin remain the treatments of choice, and recommendations are made for the penicillin-allergic patient, which now include clindamycin.

📤 Share this page

Found this useful? Share it with your network.

𝕏XfFacebookinLinkedIn✆WhatsApp✈Telegram✉EmailMMendeley
✓ Link copied! Paste it on ResearchGate / Academia.edu

🔬 Related Research Papers

Clinical Infectious Diseases

Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America

Michael Jonah Silverberg, B. Lau et al. 2012-01-30 · Read paper → Clinical Infectious Diseases

Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients

Ronza Najjar‐Debbiny, Naomi Gronich et al. 2022-06-02 · Read paper → Clinical Infectious Diseases

Outbreak of Chikungunya on Reunion Island: Early Clinical and Laboratory Features in 157 Adult Patients

Gianandréa Borgherini, Patrice Poubeau et al. 2007-05-03 · Read paper → Clinical Infectious Diseases

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR- P. aeruginosa )

Pranita D. Tamma, Samuel L Aitken et al. 2022-04-14 · Read paper → Clinical Infectious Diseases

COVID-19 in Immunocompromised Hosts: What We Know So Far

Monica Fung, Jennifer M. Babik 2020-06-24 · Read paper → Clinical Infectious Diseases

Totally Drug-Resistant Tuberculosis in India

Zarir Farokh Udwadia, Rohit Amale et al. 2011-12-21 · Read paper → Clinical Infectious Diseases

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy

Thomas P. Lodise, Ben M. Lomaestro, George L. Drusano 2007-01-16 · Read paper → Clinical Infectious Diseases

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

Stuart Johnson, Thomas Louie et al. 2014-05-05 · Read paper → Clinical Infectious Diseases

Clinical Recognition and Diagnosis ofClostridium difficileInfection

John Gilles Bartlett, Dale N. Gerding 2008-01-04 · Read paper → Clinical Infectious Diseases

A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)

Fanny Lanternier, Éric Dannaoui et al. 2012-01-13 · Read paper → Clinical Infectious Diseases

Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19)

Jasper Fuk‐Woo Chan, Shuofeng Yuan et al. 2020-05-28 · Read paper → Clinical Infectious Diseases

Human Health Consequences of Use of Antimicrobial Agents in Aquaculture

Ole Eske Heuer, Hilde Kruse et al. 2009-09-22 · Read paper →